Arnulf Stenzl

Giant solitary tumor in the true pelvis: atypical prostatic adenomyomatosis.

Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

[Photodynamic diagnostics in the urinary tract. Consensus paper of the Working Group for Oncology of the German Society for Urology].

Can we still afford bladder cancer?

Cystectomy in women.

The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.

Interpretation of the prostate cancer gene 3 in reference to the individual clinical background: implications for daily practice.

Small renal oncocytomas: differentiation with multiphase CT.

Words of wisdom. Re: sex and racial differences in bladder cancer presentation and mortality in the US.

Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results.

Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Influence of renal excretory function on the performance of urine based markers to detect bladder cancer.

[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].

Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?

Isolated, disseminated and circulating tumour cells in prostate cancer.

Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.

Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.

The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.

A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.

Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer - 5-year experience in a single-center.

Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.

Prevention and early detection of prostate cancer.

Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?

Mesenchymal stromal cells for sphincter regeneration.

Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.

Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional study.

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.

Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.

The "I-Pouch": Results of a new ileal neobladder technique.

Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?

Considerations for orthotopic diversions in women.

Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Words of Wisdom. Re: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.

Minimally invasive versus conventional large-bore percutaneous nephrolithotomy in the treatment of large-sized renal calculi: Surgeon's preference?

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.

Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.

Pathophysiology and Contributing Factors in Postprostatectomy Incontinence: A Review.

Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?

The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

Optical improvements in the diagnosis of bladder cancer: implications for clinical practice.

Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.

mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.

Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT Images.

PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.

Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer.

Preservation of the bladder, but at what cost?

Human Prostate Cancer is Characterized by an Increase in Urea Cycle Metabolites.

Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer.

Prognostic impact of somatostatin receptor expression in advanced bladder cancer.

Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes.

Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study.

Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes.

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.

Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma.

Minimal-invasive management of urological complications after kidney transplantation.

Injection of Porcine Adipose Tissue-Derived Stromal Cells by a Novel Waterjet Technology.

Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects.

Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer.

Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology.

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.